A multi-centre, prospective, clinical in-market evaluation to assess the performance of Opsite Post-Op Visible dressings.
Summary of "A multi-centre, prospective, clinical in-market evaluation to assess the performance of Opsite Post-Op Visible dressings."
The aim of this study was to assess the performance of Opsite Post-Op Visible as a post-surgical dressing in a typical clinical setting. In this multi-centre clinical evaluation, patients who underwent clean surgery were treated with Opsite Post-Op Visible dressing. Duration of dressing wear, visibility through the dressing and ability to handle exudate were assessed and the product was rated in comparison with those normally used. A total of 64 patients were recruited. Mean wear time was 4.5 days. Exudate management was rated very good or good at 96% of assessments. Visibility of the incision site was rated as very good or good at 72%, and as acceptable at 24%, of assessments. Patient comfort was rated very comfortable (63%) or comfortable (37%) at all assessments. Dressings were generally rated as satisfactory or exceeding expectations with clinicians stating that the Opsite Post-Op Visible dressing was better than the dressing they routinely used for 92% of patients. Opsite Post-Op Visible dressing is an innovative dressing combining good visibility with exudate management and patient comfort. It was found to have adequate wear time, visibility and exudate management properties making it suitable for use on a variety of surgical incision sites.
G O'Brien, Tissue Viability CNS, Naas General Hospital, Ireland.
This article was published in the following journal.
Name: International wound journal
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/20636341
- DOI: http://dx.doi.org/10.1111/j.1742-481X.2010.00689.x
A prospective multi-centre nationwide study of patients with congenital dislocation of the hip (CDH) diagnosed after 3 months of age was conducted with support from the French Society for Paediatric O...
A retrospective review of the clinical and radiographic outcomes from a multi-center study of surgical treatment for high-grade spondylolisthesis (HGS) in adults. The objective was to assess the safet...
CE-MARC was the largest prospective evaluation of the diagnostic accuracy of CMR in coronary artery disease. CE-MARC adopted a multi-parametric protocol assessing ventricular function, myocardial perf...
Despite major improvements in short term survival of organ allografts long-term graft survival has not changed significantly. It is also known that toxic side effects of current immunosuppressive drug...
Risk scoring is a useful tool for prognostication, decision-making and, increasingly, assessing individual and institutional performance. At the South Yorkshire Cardiothoracic Centre, we have been usi...
A multi-center, non-randomized, prospective post-market evaluation of sinuplasty in paranasal sinuses.
This study is planned as a prospective, randomised, parallel, controlled, multi-centre, open label, comparative evaluation of SprayShield™ Adhesion Barrier plus good surgical technique, ...
To establish a solid foundation, e.g. network and a coordinating centre for testing new SCI therapies in forthcoming randomized controlled multi-centre clinical trials following internatio...
The study is a prospective multi-centre study to investigate the effect of a new bipolar ablation strategy of the left atrium in patients with paroxysmal or permanent atrial fibrillation o...
This evaluation is being conducted to evaluate the performance of the ASR arthroplasty. The performance of the devices will be assessed by: Clinical parameters: pain, function, satisfacti...
Medical and Biotech [MESH] Definitions
Studies designed to assess the efficacy of programs. They may include the evaluation of cost-effectiveness, the extent to which objectives are met, or impact.
Educational programs structured in such a manner that the participating professionals, physicians, or students develop an increased awareness of their performance, usually on the basis of self-evaluation questionnaires.
The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance.
Studies determining the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. For drugs and devices, CLINICAL TRIALS AS TOPIC; DRUG EVALUATION; and DRUG EVALUATION, PRECLINICAL are available.
The commission charged with evaluating issues and factors which affect the implementation of the PROSPECTIVE PAYMENT SYSTEM.